Suscribirse

HEPATIC IMAGING : An Overview - 09/09/11

Doi : 10.1016/S0033-8389(05)70019-1 
Helena M. Taylor, MD, FRCR b, Pablo R. Ros, MD, FACR a, b, c
a Division of Body Imaging and MRI (PRR) 
b Department of Radiology (HMT, PRR), University of Florida College of Medicine, Gainesville, Florida 
c currently, Vice Chairman, Department of Radiology, Harvard Medical School/Brigham & Women's Hospital, Boston, Massachusetts (PRR) 

Resumen

The revolution in imaging techniques over the past few years has created a bewildering array of choices for clinicians investigating patients with suspected hepatic disease. In particular, advances in ultrasound (US), CT scan, and MR imaging have led to improved detection and characterization of liver lesions such that a definitive diagnosis can often be achieved noninvasively. Clinical information, however, is of paramount importance in selecting the appropriate imaging modality and interpreting the study accurately. The powerful combination of radiologic findings and clinical information enables the radiologist to categorize a hepatic lesion according to whether surgical management is necessary. Nonsurgical entities are lesions that, if correctly characterized by imaging, require no further attention (e.g., hemangioma; abscess, cyst; focal nodular hyperplasia; diffuse liver diseases, such as hemochromatosis and cirrhosis; and normal variants, such as focal fatty liver). Examples of surgical diagnoses include hepatocellular carcinoma, adenoma, and metastases in patients undergoing evaluation for hepatic resection. Recent developments in imaging, such as chemical shift techniques and MR imaging contrast agents, enable the radiologist confidently to categorize many lesions as nonsurgical, thereby obviating the need for interventional techniques, such as percutaneous biopsy, which have an associated morbidity. Within the surgical group, imaging plays a key role in identifying disease extent, which has important prognostic and therapeutic implications. For example, the number and size of hepatic metastases from colorectal neoplasms as well as the presence of extrahepatic disease are major determinants of long-term survival in patients undergoing hepatic resection.1, 46 Accurate preoperative evaluation of tumor burden by imaging techniques is therefore a central issue in the assessment of these patients. Clearly, radiologists are now in a unique position to influence directly the management of patients with liver lesions provided that the relevant technology and clinical information are available. We review the importance of clinical information in the interpretation of imaging studies, emphasize the impact on patient management of cross-sectional imaging techniques, and provide an overview of recent advances in US, CT scan, MR imaging, and scintigraphy, which are elaborated elsewhere in this issue.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Pablo R. Ros, MD, Harvard Medical School, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02215


© 1998  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 36 - N° 2

P. 237-245 - mars 1998 Regresar al número
Artículo precedente Artículo precedente
  • PREFACE
  • PABLO R. ROS
| Artículo siguiente Artículo siguiente
  • CT SCAN OF THE LIVER
  • Scott R. Kemmerer, Koenraad J. Mortele, Pablo R. Ros

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.